SHR0302 Base Gel

DRUG2 trials

Sponsors

Jiangsu HengRui Medicine Co., Ltd.

Conditions

Non-segmental VitiligoPreoperative Sedation of Adults

Phase 1

A Randomized, Double-blind, Placebo-controlled Phase I Clinical Trial to Evaluate the Safety and Pharmacokinetic Profile of Single and Multiple Dose Escalation Topical Dermal Administration of SHR0302 Alkali Gel in Healthy Subjects

CompletedNCT07098117

Jiangsu HengRui Medicine Co., Ltd.Preoperative Sedation of Adults

Start: 2024-06-19End: 2024-07-31Updated: 2025-08-01

Phase 2

A Trial of SHR0302 Tablets and SHR0302 Base Gel in Patients With Non-segmental Vitiligo

RecruitingNCT07251595

Jiangsu HengRui Medicine Co., Ltd.Non-segmental Vitiligo

Start: 2025-12-05End: 2027-09-01Target: 176Updated: 2026-02-18